IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
This study has been completed.
Sponsor:
Immutep S.A.
Collaborator:
Umanis
Information provided by:
Immutep S.A.
ClinicalTrials.gov Identifier:
NCT00349934
First received: July 7, 2006
Last updated: January 6, 2010
Last verified: January 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | January 2010 |
| Primary Completion Date: | November 2009 (Final data collection date for primary outcome measure) |
No publications provided by Immutep S.A.
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):